Chris de Souza
Director/Board Member presso Gila Therapeutics, Inc.
Profilo
Chris de Souza is currently a Director at Mellitus LLC, Broadview Ventures, Inc., Acesion Pharma ApS, and Gila Therapeutics, Inc. He previously served as Chairman at British Heart Foundation from 2018 to 2021.
He also held director positions at DecImmune Therapeutics, Inc., NupulseCV, Inc., Massachusetts Biotechnology Council, Provasculon, Inc., VentriNova, Inc., and Herantis Pharma Oyj.
Additionally, he was a Principal at Novartis, Inc. and JSB-Partners LP, and a Vice President at Pacira Pharmaceuticals, Inc. (California) and Skyepharma US, Inc. from 2007 to 2010.
Dr. de Souza holds an MBA from Rutgers State University of New Jersey, a doctorate from Louisiana State University, and a graduate degree from the University of Mumbai.
Posizioni attive di Chris de Souza
| Società | Posizione | Inizio |
|---|---|---|
Broadview Ventures, Inc.
 Broadview Ventures, Inc. Investment ManagersFinance Broadview Ventures, Inc. (Broadview Ventures) is a venture capital firm founded in 2008. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 01/06/2012 |
Mellitus LLC
 Mellitus LLC BiotechnologyHealth Technology Mellitus LLC develops vitro diagnostic tests for the measurement of Glycated CD59 (GCD59). Its vitro diagnostic test is also used for the stratification of complications risk and as a clinical trial test for pharmaceutical development. The company was founded by Jose Alberto Halperin, Joyce A. Lonergan and Michael Chorev in 2011 and is headquartered in Boston, MA. | Director/Board Member | 01/05/2017 |
Gila Therapeutics, Inc.
 Gila Therapeutics, Inc. Other Consumer ServicesConsumer Services Gila Therapeutics, Inc. provides developing therapies for obesity patients. The company was founded by Sergei Zolotukhin and Andres Acosta in January 2014 and is headquartered in Excelsior, MN. | Director/Board Member | 01/04/2016 |
Acesion Pharma ApS
 Acesion Pharma ApS Pharmaceuticals: MajorHealth Technology Acesion Pharma ApS develops drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The firm's technology blocks ion channel with a selective drug molecule constitutes a target for developing treatment of AF. The company was founded by Ulrik Svane S?rensen and Morten Grunnet in 2011 and is headquartered in Copenhagen, Denmark. | Director/Board Member | 01/12/2014 |
Precedenti posizioni note di Chris de Souza
| Società | Posizione | Fine |
|---|---|---|
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Director/Board Member | 30/11/2021 |
| Giner Life Sciences, Inc. | Director/Board Member | 01/11/2021 |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Director/Board Member | 01/11/2021 |
| Giner Life Sciences, Inc. | Director/Board Member | 31/10/2021 |
| British Heart Foundation | Chairman | 01/05/2021 |
Formazione di Chris de Souza
| Rutgers State University of New Jersey | Masters Business Admin |
| Louisiana State University | Doctorate Degree |
| University of Mumbai | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| HERANTIS PHARMA OYJ | Health Technology |
| Aziende private | 15 |
|---|---|
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Health Technology |
JSB-Partners LP
 JSB-Partners LP Investment Banks/BrokersFinance JSB-Partners LP offers specialized investment banking and advisory services to biotechnology and pharmaceutical companies. Its services include product partnerships, mergers and acquisitions, private placements and public underwritings. The company was founded by Wolfgang Rudolph Ralph Stoiber in 1999 and is headquartered in Boston, MA. | Finance |
DecImmune Therapeutics, Inc.
 DecImmune Therapeutics, Inc. BiotechnologyHealth Technology DecImmune Therapeutics, Inc. develops novel peptides and antibodies for acute and tissue damaging inflammation. It engages in developing an antibody-based therapeutic that can prevent tissue damage and preserve organ function by inhibiting activation of the N2 neoepitope in the innate autoimmune pathway. The company was founded by Michael Carroll, Richard S. Foemmel, and Francis Moore Jr. on March 27, 2001 and is headquartered in Cambridge, MA.^ | Health Technology |
NupulseCV, Inc.
 NupulseCV, Inc. Medical SpecialtiesHealth Technology NupulseCV, Inc. operates as a medical device company that develops technology to treat patients with heart failure. Its device which requires a minimally invasive surgery provides patients an alternative to medical therapy. The firm maintains strategic and financial partnership with heart failure companies around the world. The company was founded in 2010 and is headquartered in Raleigh, NC. | Health Technology |
Mellitus LLC
Mellitus LLC BiotechnologyHealth Technology Mellitus LLC develops vitro diagnostic tests for the measurement of Glycated CD59 (GCD59). Its vitro diagnostic test is also used for the stratification of complications risk and as a clinical trial test for pharmaceutical development. The company was founded by Jose Alberto Halperin, Joyce A. Lonergan and Michael Chorev in 2011 and is headquartered in Boston, MA. | Health Technology |
| British Heart Foundation | Commercial Services |
Pacira Pharmaceuticals, Inc. (California)
 Pacira Pharmaceuticals, Inc. (California) Medical SpecialtiesHealth Technology Pacira Pharmaceuticals, Inc. develops and manufactures injectable and sustained release therapeutic products. It focuses on clinical and commercial development activities by understanding the needs of the acute care market. The company was founded in March 2007 and is headquartered in San Diego, CA. | Health Technology |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Commercial Services |
Provasculon, Inc.
 Provasculon, Inc. Pharmaceuticals: MajorHealth Technology Provasculon, Inc. developed new treatments for chronic wounds and cardiovascular diseases. The company was founded by Thomas Lee Richard and Vincent M. Segers in 2008 and was headquartered in Boston, MA. | Health Technology |
Broadview Ventures, Inc.
Broadview Ventures, Inc. Investment ManagersFinance Broadview Ventures, Inc. (Broadview Ventures) is a venture capital firm founded in 2008. The firm is headquartered in Boston, Massachusetts. | Finance |
Acesion Pharma ApS
Acesion Pharma ApS Pharmaceuticals: MajorHealth Technology Acesion Pharma ApS develops drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The firm's technology blocks ion channel with a selective drug molecule constitutes a target for developing treatment of AF. The company was founded by Ulrik Svane S?rensen and Morten Grunnet in 2011 and is headquartered in Copenhagen, Denmark. | Health Technology |
VentriNova, Inc.
 VentriNova, Inc. Pharmaceuticals: MajorHealth Technology VentriNova, Inc. develops gene therapy for the regeneration of heart tissue in patients with heart failure and after myocardial infarction. The company was founded by Hina Waheed Chaudhry in 2006 and is headquartered in New York, NY. | Health Technology |
Gila Therapeutics, Inc.
Gila Therapeutics, Inc. Other Consumer ServicesConsumer Services Gila Therapeutics, Inc. provides developing therapies for obesity patients. The company was founded by Sergei Zolotukhin and Andres Acosta in January 2014 and is headquartered in Excelsior, MN. | Consumer Services |
| Skyepharma US, Inc. | |
| Giner Life Sciences, Inc. |
- Borsa valori
- Insiders
- Chris de Souza
